solver.press

Modeling the evolutionary trade-offs of antibiotic resistance using coalition-based equilibrium concepts will identify conditions where coordinated gene mutations enable multi-drug resistance with reduced fitness penalties.

BiologyJun 9, 2026Evaluation Score: 63%

Adversarial Debate Score

60% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

ChatGPT: The hypothesis is falsifiable and builds on established knowledge that antibiotic resistance involves evolutionary trade-offs, and that compensatory or coordinated mutations can mitigate fitness costs; however, the concept of "coalition-based equilibrium" is novel and not directly supported by th...
Mistral: The hypothesis is falsifiable and aligns well with existing literature on fitness trade-offs and compensatory mutations, but its reliance on "coalition-based equilibrium" concepts lacks direct empirical support in the cited papers, leaving room for counterarguments about scalability and mechanist...
Gemini: The hypothesis is falsifiable and builds on well-established concepts of trade
Grok: The hypothesis builds on real trade-offs and compensatory mutations shown in the papers but proposes coalition-based equilibrium modeling that none of the excerpts address or support, making the specific claim speculative and weakly grounded.

Supporting Research Papers

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Modeling the evolutionary dynamics of bacterial populations exposed to multiple antibiotics using coalition-based equilibrium concepts (e.g., cooperative game-theoretic models) will reveal specific conditions—quantifiable in terms of gene mutation rates, fitness penalties, and antibiotic concentrations—under which coordinated gene mutations result in multi-drug resistance with lower combined fitness costs than would result from independent acquisition of resistance.

Disproof criteria:
  • No statistically significant reduction in combined fitness penalties is observed in populations with coordinated mutations compared to those with independently acquired resistance (p > 0.05, two-tailed t-test).
  • Coalition-based models do not outperform standard evolutionary models (e.g., individual Nash equilibria) in predicting observed resistance patterns (measured by AUC or RMSE; difference <5%).
  • No conditions are identified where coordinated gene mutations confer multi-drug resistance at a lower fitness cost than the sum of independent mutations.

Spine & Adversarial ReadReady for validation

Coalition-based equilibrium models can identify conditions where coordinated gene mutations enable multi-drug resistance with reduced fitness penalties compared to independent mutation acquisition.

  • highThe chosen coalition-based modeling framework may not fully capture the biological mechanisms of gene interaction, leading to overfitting or under-explaining observed resistance patterns.
    Partially addressed by including benchmarking against standard evolutionary models and by using empirical fitness data for model parameterization; however, the biological realism of coalition concepts requires further validation.
  • mediumWhy use E. coli and these specific antibiotics? Are the results generalizable to other pathogens or drugs?
    E. coli is a standard model organism with well-characterized genetics and available tools, making it ideal for controlled experiments; subsequent studies could generalize to other species. The protocol's boundary conditions should be updated if generalization is a core claim.
  • mediumLimited sample size or experimental noise could mask subtle fitness differences, undermining statistical power.
    Sample sizes and replication are explicitly set to ensure >80% power to detect 15% fitness penalty differences; QC and abort checkpoints are included to catch these issues early.

Experimental Protocol

  1. Select two model bacterial strains (e.g., E. coli K-12) and two antibiotics with non-overlapping targets (e.g., ciprofloxacin and tetracycline).
  2. Engineer single and double mutants with known resistance-conferring alleles, both independently and in combination.
  3. Conduct competitive fitness assays in controlled media with various antibiotic concentrations.
  4. Use whole-genome sequencing to confirm mutations and monitor population dynamics over 100 generations.
  5. Build and fit coalition-based game-theoretic models (e.g., Shapley value or core stability analysis) to the experimental fitness and prevalence data.
  6. Compare model predictions to empirical outcomes to identify conditions matching the hypothesis.
  7. Run control experiments with models that do not incorporate coalition concepts for benchmarking.
Required datasets:
  • Whole-genome sequencing data from ancestral, single-mutant, and double-mutant strains (Illumina HiSeq, ~100x coverage, N = 50 samples).
  • Fitness assay results: OD600, colony counts, and growth rates for each genotype under all antibiotic conditions (N = 1200 measurements).
  • Time-series population composition data (amplicon sequencing, N = 30 timepoints per lineage).
  • Antibiotic concentration-response curves (N = 12 per antibiotic).
  • Annotated mutation effect database (e.g., CARD or ResFinder for known resistance genes).
Success:
  • Coalition-based models predict observed multi-drug resistance patterns with RMSE at least 10% lower (or AUC at least 0.05 higher) than non-coalitional models.
  • In at least 30% of tested conditions, double mutants demonstrate fitness penalties at least 15% lower than the sum of single mutants (statistically significant, p < 0.05).
  • At least one parameter regime is identified where coordinated mutations confer lower penalty than independent mutation sum in >2 independent lineages.
Failure:
  • No significant difference in predictive performance between coalition-based and standard models.
  • Double-mutant fitness penalties never fall below the sum of single-mutant penalties in any tested condition.
  • Experimental or modeling results are not reproducible across lineages (variance >25%).

30

GPU hours

120d

Time to result

$6,500

Min cost

$18,500

Full cost

ROI Projection

Commercial:
  • High: Pharmaceutical development (antibiotic stewardship, new drug design), clinical diagnostics (predictive resistance modeling), and public health policy (treatment regimen optimization).
  • Estimated market impact: $10M–$50M annually for hospital and pharmaceutical applications.

Implementation Sketch

Architecture Overview:

  • Modular pipeline:
    1. Experimental Data Generation
    2. Data Ingestion & Preprocessing
    3. Model Construction
    4. Model Fitting & Simulation
    5. Analysis & Output Visualization

1. Experimental Data Generation:

  • Lab automation scripts for culturing, plating, and sampling (Python + robotic interface).
  • Sequencing pipeline (Illumina base-calling, QC).

2. Data Ingestion & Preprocessing:

# Pseudocode for data pipeline
def ingest_data(seq_files, fitness_files):
    seq_data = load_fastq(seq_files)
    fitness_data = load_csv(fitness_files)
    seq_data_qc = quality_filter(seq_data, threshold=30)
    fitness_data = normalize(fitness_data)
    return seq_data_qc, fitness_data

3. Model Construction:

  • Represent each resistance gene as a "player" in a coalition game.
  • Define payoff matrix where payoffs = measured fitness under each antibiotic condition.
  • Incorporate epistatic interaction terms (e.g., fitness_penalty(A+B) ≠ penalty(A) + penalty(B)).
class CoalitionGame:
    def __init__(self, genes, fitness_matrix):
        self.genes = genes
        self.fitness_matrix = fitness_matrix
        self.coalitions = generate_all_coalitions(genes)
    def payoff(self, coalition):
        return self.fitness_matrix[coalition]

4. Model Fitting & Simulation:

  • Fit model parameters to experimental data (e.g., least-squares for fitness penalties, MCMC for mutation rates).
  • Simulate evolutionary dynamics using replicator equations or agent-based models.
def fit_parameters(fitness_data, mutation_data):
    # Fit fitness penalties using nonlinear regression
    params = optimize_least_squares(fitness_model, fitness_data)
    # Fit mutation rates to observed frequencies
    mutation_params = infer_mutation_rates(mutation_data)
    return params, mutation_params

def simulate_evolution(params, mutation_params, generations=100):
    pop = initialize_population()
    for gen in range(generations):
        pop = evolve_population(pop, params, mutation_params)
    return pop

5. Analysis & Output Visualization:

  • Compare model predictions with observed population frequencies and fitness.
  • Report key metrics: RMSE, AUC, fitness penalty reductions.
def evaluate_model(predictions, observations):
    rmse = calc_rmse(predictions, observations)
    auc = calc_auc(predictions, observations)
    return rmse, auc

def report_results(rmse, auc, penalty_reduction):
    print(f"RMSE: {rmse}, AUC: {auc}, Penalty Reduction: {penalty_reduction}")
    plot_fitness_landscape()
    plot_population_dynamics()

Controls:

  • Parallel experiments with models omitting coalition terms.
  • Control populations without selective pressure.

Outputs:

  • Quantitative tables: fitness penalties, model fit statistics, parameter regimes.
  • Visualizations: fitness landscapes, population dynamics, coalition stability diagrams.
Abort checkpoints:
  • After initial fitness assays: if measured fitness penalties are not distinguishable (>10% error), abort.
  • After 20 generations: if no double mutants emerge, abort or redesign.
  • After initial model fitting: if RMSE reduction <2% over baseline, abort further modeling.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started